Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.78 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.62 |
| ▸ | IGF2R | P11717 | 4/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | UMPS | P11172 | 2/20 | 0.43 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15628068 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL977102 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL9117406 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL345396 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL12377166 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL799813 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL48379 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL21926734 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL22107998 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL742653 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170281772-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-10-05 | — | — | US | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-20060251635-A1 | Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2006-11-09 | — | — | US | disclosed |
| US-7052896-B2 | Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them | VIALACTIA BIOSCIENCE (NZ) LIMITED (NZ) | 2006-05-30 | — | — | US | disclosed |
| EP-1311684-A4 | LACTOBACILLUS RHAMNOSUS POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS FOR USING THEM | GENESIS RES & DEV CORP LTD (NZ) | 2005-10-19 | — | — | EP | disclosed |
| EP-1311684-A1 | LACTOBACILLUS RHAMNOSUS POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS FOR USING THEM | Genesis Research & Development Corporation Limited (NZ) | 2003-05-21 | — | — | EP | disclosed |
| US-20020159976-A1 | Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them | VIALACTIA BIOSCIENCE (NZ) LIMITED (NZ) | 2002-10-31 | — | — | US | disclosed |
| WO-2002012506-A1 | LACTOBACILLUS RHAMNOSUS POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS FOR USING THEM | GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (NZ) | 2002-02-14 | — | — | WO | disclosed |
| US-6102690-A | Recombinant organisms capable of fermenting cellobiose | UNIV. OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2000-08-15 | — | — | US | disclosed |
| EP-0973915-A1 | RECOMBINANT MICROORGANISMS CAPABLE OF FERMENTING CELLOBIOSE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998045451-A1 | RECOMBINANT MICROORGANISMS CAPABLE OF FERMENTING CELLOBIOSE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1998-10-15 | — | — | WO | disclosed |